Mitochondrial quality control as a therapeutic target in cardiovascular disease: Mechanistic insights and future directions
Journal of Translational Internal Medicine · 26.06.2025 · 13 (3) · 211-240
DOI: 10.1515/jtim-2025-0030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Translational Internal Medicine, online erschienen am 20.06.2025. Verfasst von Miao Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 255 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Mitochondrial dysfunction is increasingly recognized as a critical driver in the pathogenesis of cardiovascular diseases. Mitochondrial quality control (MQC) is an ensemble of adaptive mechanisms aimed at maintaining mitochondrial integrity and functionality and is essential for cardiomyocyte viability and optimal cardiac performance under the stress of cardiovascular pathology. The key MQC components include mitochondrial fission, fusion, mitophagy, and mitochondria-dependent cell death, each contributing uniquely to cellular homeostasis. The dynamic interplay among these processes is intricately linked to pathological phenomena, such as redox imbalance, calcium overload, dysregulated energy metabolism, impaired signal transduction, mitochondrial unfolded protein response, and endoplasmic reticulum stress. Aberrant mitochondrial fission is an early marker of mitochondrial injury and cardiomyocyte apoptosis, whereas reduced mitochondrial fusion is frequently observed in stressed cardiomyocytes and is associated with mitochondrial dysfunction and cardiac impairment. Mitophagy is a protective, selective autophagic degradation process that eliminates structurally compromised mitochondria, preserving mitochondrial network integrity. However, dysregulated mitophagy can exacerbate cellular injury, promoting cell death. Beyond their role as the primary energy source of the cell, mitochondria are also central regulators of cardiomyocyte survival, mediating apoptosis and necroptosis in reperfused myocardium. Consequently, MQC impairment may be a determining factor in cardiomyocyte fate. This review consolidates current insights into the regulatory mechanisms and pathological significance of MQC across diverse cardiovascular conditions, highlighting potential therapeutic avenues for the clinical management of heart diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmacy, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.
- Heart Failure Center, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong Province, China.
- Department of Cardiovascular Surgery, Guangdong Provincial Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.
- The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.
- State Key Laboratory of Dampness Syndrome of Chinese Medicine, Guangzhou, Guangdong Province, China.
- Department of Cardiology, Chinese PLA General Hospital, Beijing, China.
Zitieren
APA
Zhang, M., Zhang, T., Zou, R., He, K., Huang, R., Feng, J., Hu, J., Ge, T., Fan, X., Zhou, H., & Chen, Y. (2025). Mitochondrial quality control as a therapeutic target in cardiovascular disease: Mechanistic insights and future directions. Journal of Translational Internal Medicine, 13(3), 211-240. https://doi.org/10.1515/jtim-2025-0030
Vancouver
Zhang M, Zhang T, Zou R, He K, Huang R, Feng J, et al. Mitochondrial quality control as a therapeutic target in cardiovascular disease: Mechanistic insights and future directions. Journal of Translational Internal Medicine. 2025;13(3):211-240. doi:10.1515/jtim-2025-0030
BibTeX
@article{Zhang2025,
author = {Zhang, Miao and Zhang, Tong and Zou, Rongjun and He, Kunyang and Huang, Ru and Feng, Jingrui and Hu, Jinlin and Ge, Teng and Fan, Xiaoping and Zhou, Hao and Chen, Yang},
title = {Mitochondrial quality control as a therapeutic target in cardiovascular disease: Mechanistic insights and future directions},
journal = {Journal of Translational Internal Medicine},
year = {2025},
volume = {13},
number = {3},
pages = {211--240},
doi = {10.1515/jtim-2025-0030}
}
EUVIMED